A cancer with a high frequency of mutational YAP/TAZ-TEAD activation is malignant pleural mesothelioma, an asbestos-induced lung tumor where forty percent of patients have deletions or loss-of-function mutations in LATS1, NF2, RASSF1, or SAV170. The gene discussed is NF2; the disease is cancer.